Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Non-Current Assets (2016 - 2025)

Bioadaptives' Non-Current Assets history spans 5 years, with the latest figure at $14000.0 for Q4 2025.

  • On a quarterly basis, Non-Current Assets changed N/A to $14000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $46500.0, a 158.33% increase, with the full-year FY2025 number at $14000.0, changed N/A from a year prior.
  • Non-Current Assets hit $14000.0 in Q4 2025 for Bioadaptives, down from $15500.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for BDPT hit a ceiling of $166625.0 in Q3 2023 and a floor of $1644.0 in Q2 2023.
  • Historically, Non-Current Assets has averaged $36789.8 across 5 years, with a median of $16250.0 in 2025.
  • Biggest five-year swings in Non-Current Assets: plummeted 96.38% in 2022 and later surged 4435.25% in 2023.
  • Tracing BDPT's Non-Current Assets over 5 years: stood at $59709.0 in 2021, then plummeted by 94.99% to $2990.0 in 2022, then surged by 416.42% to $15441.0 in 2023, then grew by 16.57% to $18000.0 in 2024, then dropped by 22.22% to $14000.0 in 2025.
  • Business Quant data shows Non-Current Assets for BDPT at $14000.0 in Q4 2025, $15500.0 in Q3 2025, and $17000.0 in Q2 2025.